EXOSEAL血管闭合装置与手动压迫在经肱动脉介入术中效果与安全性的回顾性比较
本研究回顾性比较了EXOSEAL血管闭合装置(EVCD)与手动压迫(MC)在Stanford B型主动脉夹层患者经肱动脉介入术后止血的效果与安全性。共纳入157例患者,EVCD组107例,MC组50例。EVCD组止血时间显著缩短,但出现若干主要并发症,而MC组无主要并发症;MC组小并发症(血肿、瘀斑)发生率更高。
要点
- EVCD组止血时间显著短于MC组(P<0.05)。
- EVCD组出现血管修复、输血等主要并发症,MC组无主要并发症。
- MC组血肿和瘀斑发生率显著高于EVCD组(P=0.030和P=0.001)。
核心结论
- 在经6F肱动脉穿刺且术前完全抗凝的患者中,EVCD较MC显著缩短止血时间,但EVCD组出现主要并发症而MC组无主要并发症。
- MC止血更安全方便,但小并发症发生率更高。
研究设计与样本
- 回顾性研究,纳入2016年3月至2017年10月期间接受经肱动脉介入治疗的Stanford B型主动脉夹层患者157例。
- EVCD组107例,MC组50例,两组基线特征相似。
主要发现
- 止血时间(TTH)EVCD组显著短于MC组(P<0.05)。
- MC组TTH≥10分钟为100.0%(n=50);EVCD组TTH≤2分钟为87.9%(n=107),2-5分钟为7.5%(n=107),≥10分钟为4.7%(n=107)。
- EVCD组主要并发症:2例(1.9%,n=107)需血管修复,1例(0.6%,n=107)需输血,1例(0.6%,n=107)出现上肢麻木无力;MC组无主要并发症。
- 小并发症:血肿(≤5 cm)MC组4例(8.0%),EVCD组4例(3.7%),差异有统计学意义(P=0.030);瘀斑MC组13例(26.0%),EVCD组8例(7.5%),差异有统计学意义(P=0.001)。
临床怎么用
- 对于经肱动脉介入且术前完全抗凝的患者,EVCD可缩短止血时间,但需警惕主要并发症风险。
- MC虽小并发症较多,但无主要并发症,可作为安全方便的止血选择。
局限性
- 回顾性研究设计,可能存在选择偏倚。
- 样本量有限,EVCD组主要并发症发生率低,需更大样本验证。
- 单中心研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to assess the safety and efficacy of EXOSEAL vascular closure device (EVCD) insertion by comparing its performance with manual compression (MC) in achieving hemostasis at the brachial artery puncture site. METHODS: A retrospective study of brachial artery access by using either MC or EVCD for achieving hemostasis from March 2016 to October 2017 was conducted. Patients with Stanford type B aortic dissection (TBAD) undergoing percutaneous transbrachial procedures were included. Time to hemostasis (TTH) was the primary efficacy end point. Seven-day incidence of major access site-related complications was the primary safety end point. TTH and major and minor complications associated with treatment of these 2 groups were also evaluated. RESULTS: A total of 157 patients with TBAD undergoing percutaneous transbrachial procedures entered the analysis. Of these, 107 patients underwent EVCD insertion and 50 patients underwent MC. The baseline characteristics of the 2 groups were similar. TTH was significantly shorter for EVCD over MC (P < 0.05). The TTH ≥10 min in the MC group was 100.0% (n = 50), but in the EVCD group, it was ≤2 min, 87.9% (n = 107); 2-5 min, 7.5% (n = 107); and ≥10 min, 4.7% (n = 107). The EVCD group had several major complications, while the MC group had none. Two patients (1.9%, n = 107) required vascular repair, one patient (0.6%, n = 107) required blood transfusion, and 1 patient (0.6%, n = 107) developed upper limb numbness and weakness after EVCD deployment. Minor complication such as the occurrence of hematoma (≤5 cm) in the MC group was 4 (8.0%) but was also 4 (3.7%) in the EVCD group, showing statistically significant difference (P = 0.030). The incidence of ecchymosis was 8 (7.5%) in the EVCD group when compared with 13 (26.0%) in the MC group, which showed statistically significant difference (P = 0.001). Other major and minor complications showed no significant differences between these 2 groups. CONCLUSIONS: After invasive procedures by 6F percutaneous access via the brachial artery in preprocedurally fully anticoagulated patients, TTH was significantly reduced in patients who underwent EVCD when compared with patients who underwent MC. MC is a safer and more convenient way to achieve hemostasis but has higher incidence of minor complications.
引用
- Wei X, Han T, Sun Y, et al. A Retrospective Study Comparing the Effectiveness and Safety of EXOSEAL Vascular Closure Device to Manual Compression in Patients Undergoing Percutaneous Transbrachial Procedures. Ann Vasc Surg. 2019. PMID: 31449959. doi:10.1016/j.avsg.2019.06.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。